Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1.
Interleukin-8 (IL8/CXCL8) is present in decidua and trophoblast, which also expresses the IL8 receptors, CXCR1 and CXCR2. IL8 was shown to stimulate trophoblast migration. Matrix metalloproteinase (MMP)2, MMP9, and integrins alpha(5)beta(1) and alpha(1)beta(1) were found to play important roles in trophoblast invasion. We hypothesized that IL8 would increase this cell migration and invasion by HTR-8/SVneo cells through the activity of MMPs and integrins. Isolated first trimester of pregnancy cytotrophoblast (CT) and HTR-8/SVneo cell line were used. Migration was studied by monolayer wounding test, and invasion by Matrigel invasion test. The effects of IL8 on MMPs and integrin subunit expression were determined in HTR-8/SVneo cells by gelatin zymography and western blot respectively. The results that were obtained showed that exogenous IL8 stimulated HTR-8/SVneo cell migration and invasion. MMP2 and MMP9 levels were stimulated to 182% (P<0.01) and 134% (P<0.01) respectively. Integrin alpha(5) expression was increased to 119% (P<0.05) and integrin beta(1) expression to 173% (P<0.001) of the control values. The data that were obtained show for the first time the sensitivity of the HTR-8/SVneo cells, in addition to isolated first trimester CT, to IL8. Exogenous IL8/CXCL8 increased trophoblast cell migration and invasion, which may be partly attributable to stimulation of MMP2 and MMP9 levels and an increase in integrins. HTR-8/SVneo cell viability and proliferation were also increased.
Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Belgrade, Serbia.
Milica
M
Jovanović
Ivana
I
Stefanoska
Ljiljana
L
Radojcić
Ljiljana
L
Vićovac
D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D039482:Integrin alpha5 / Q000378:metabolism* / Q000502:physiology; D019012:Integrin beta1 / Q000378:metabolism* / Q000502:physiology; D016209:Interleukin-8 / Q000494:pharmacology*; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism* / Q000502:physiology; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism* / Q000502:physiology; D011247:Pregnancy; D014327:Trophoblasts / Q000187:drug effects* / Q000502:physiology; D015854:Up-Regulation / Q000187:drug effects
D039482:Integrin alpha5; D019012:Integrin beta1; D016209:Interleukin-8; C522361:MMP2 protein, human; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9